Eiger biopharmaceuticals, inc. (EIGR)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and cash equivalents

22,629

39,373

19,406

58,421

63,407

61,262

16,927

33,323

33,247

32,035

13,078

11,197

14,451

27,756

56,294

45,399

-

4,778

37,092

50,041

50,018

-

14,367

13,371

53,877

7,903

Debt securities, available-for-sale

54,978

55,621

90,545

66,914

22,385

39,091

48,013

40,169

-

9,744

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term marketable securities

-

-

-

-

-

-

-

-

-

-

19,264

29,112

34,573

32,180

-

-

-

0

-

-

-

-

-

-

-

-

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

61,197

-

-

-

-

776

-

-

-

-

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,004

20,570

-

80,755

37,801

3,752

10,467

Prepaid expenses and other current assets

4,858

5,390

4,459

3,033

2,594

1,492

1,864

1,485

617

712

783

969

529

581

912

1,160

475

717

1,001

1,165

1,673

31

891

590

585

180

Total current assets

82,465

100,384

114,410

128,368

88,386

101,845

66,804

74,977

33,864

42,491

33,125

41,278

49,553

60,517

57,206

46,559

61,672

5,495

38,093

59,210

72,261

808

96,013

51,762

58,214

18,550

Property and equipment, net

638

590

538

200

155

167

185

71

68

79

90

101

90

76

79

67

46

41

133

616

793

7

616

367

353

308

Operating lease right-of-use assets

1,539

1,654

1,659

1,761

1,861

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

3,781

2,511

3,388

2,598

2,706

436

389

290

289

312

66

81

124

143

142

145

155

46

10

127

185

-

280

149

11

2,296

Total assets

88,423

105,139

119,995

132,927

93,108

102,448

67,378

75,338

34,221

42,882

33,281

41,460

49,767

60,736

57,427

46,771

61,873

5,582

38,236

59,953

73,239

816

96,909

52,278

58,578

21,154

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

8,873

6,414

9,057

7,194

5,523

5,830

6,517

4,438

3,025

3,183

4,167

4,468

3,187

2,639

4,075

1,254

6,062

1,940

-

-

-

59

-

-

-

-

Accrued liabilities

4,009

10,001

7,222

5,671

4,863

4,194

1,459

1,152

1,224

2,084

1,566

1,422

910

2,649

1,272

1,535

2,049

1,006

-

-

-

226

-

-

-

-

Current portion of operating lease liabilities

551

534

466

452

439

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long term debt

-

-

-

-

-

-

6,565

3,242

3,253

2,002

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible promissory note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,444

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,025

3,446

3,746

-

3,959

2,145

1,754

2,908

Accrued restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

609

2,392

-

-

-

-

-

-

Accrued clinical expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

163

342

646

-

867

1,523

2,208

1,478

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

69

71

-

86

-

-

14

Current portion of long-term obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,587

1,671

-

-

-

-

-

Convertible notes, net of discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,044

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,116

Total current liabilities

13,433

16,949

16,745

13,317

10,825

10,024

14,541

8,832

7,502

7,269

5,733

5,890

4,097

5,288

5,347

2,789

8,111

8,390

1,797

16,836

6,134

285

4,912

3,668

3,962

6,560

Long-term obligations, net of discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

8,710

-

-

-

-

-

Long-term debt, net

30,581

30,390

30,202

30,019

29,844

25,620

18,856

17,032

11,938

13,091

-

-

-

14,727

-

-

-

-

-

-

-

-

9,911

-

-

-

Operating lease liabilities

1,188

1,320

1,389

1,512

1,631

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long term debt, net

-

-

-

-

-

-

-

-

-

-

14,993

14,898

14,800

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

885

-

-

-

-

-

-

-

-

Obligation to issue common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,457

-

-

-

-

-

-

-

-

Other long term liabilities

-

-

-

-

-

212

214

193

50

-

-

-

-

-

15

15

15

2

-

-

291

-

-

-

-

-

Total liabilities

45,202

48,659

48,336

44,848

42,300

35,856

33,611

26,057

19,490

20,360

20,726

20,788

18,897

20,015

5,362

2,804

8,126

10,734

-

-

-

285

-

-

-

-

Non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29

283

-

-

111

46

-

37

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35

-

Commitments and contingencies (Note 13)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

0

0

0

0

0

0

0

Preferred stock, value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

57,086

Stockholders’ equity:
Preferred stock, value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

15,366

0

0

0

0

Common stock

24

24

24

24

19

19

14

14

11

11

8

8

8

8

8

7

7

-

24

24

24

0

23

18

18

-

Additional paid-in capital

299,849

297,863

296,121

293,963

239,170

237,795

188,455

186,833

142,357

141,320

120,462

119,413

118,467

117,086

115,647

96,180

92,759

1,552

222,492

222,510

221,266

1,113

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

217,058

175,268

174,311

61,593

Accumulated other comprehensive income

36

42

43

5

5

-25

-6

-14

-

-3

-2

-6

-8

-15

-

-

-

-

-

-

-1

-

-8

18

-

2

Accumulated deficit

-256,688

-241,449

-224,529

-205,913

-188,386

-171,197

-154,696

-137,552

-127,637

-118,806

-107,913

-98,743

-87,597

-76,358

-63,590

-52,220

-39,019

-29,271

-186,106

-179,710

-163,185

-15,949

-135,098

-

-

-112,586

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

126,740

119,748

-

Total stockholders’ equity

43,221

56,480

71,659

88,079

50,808

66,592

33,767

49,281

14,731

22,522

12,555

20,672

30,870

40,721

52,065

43,967

53,747

-5,152

36,410

42,824

58,104

530

81,975

48,564

54,581

-50,991

Total liabilities and stockholders’ equity

88,423

105,139

119,995

132,927

93,108

102,448

67,378

75,338

34,221

42,882

33,281

41,460

49,767

60,736

57,427

46,771

61,873

5,582

38,236

59,953

73,239

816

96,909

52,278

58,578

21,154